Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael P Menden

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Biomolecules|July 2, 2020
Concise Polygenic Models for Cancer-Specific Identification of Drug-Sensitive Tumors from Their Multi-Omics ProfilesStefan Naulaerts, Michael P Menden, Pedro J Ballester
Expert Opinion on Drug Discovery|June 16, 2022
Can artificial intelligence accelerate preclinical drug discovery and precision medicine?Ali Farnoud, Alexander J Ohnmacht, Martin Meinel, et al.
Expert Opinion on Drug Discovery|October 27, 2023
Generative artificial intelligence empowers digital twins in drug discovery and clinical trialsMaria Bordukova, Nikita Makarov, Raul Rodriguez-Esteban, et al.
Plos One|May 11, 2026
Systematic identification of pan-cancer single-gene expression biomarkers in drug high-throughput screensGinte Kutkaite, Göksu Avar, Diyuan Lu, et al.
Expert Opinion on Drug Discovery|June 2, 2021
Artificial intelligence in early drug discovery enabling precision medicineFabio Boniolo, Emilio Dorigatti, Alexander J Ohnmacht, et al.
NPJ Systems Biology and Applications|June 4, 2020
Stratification and prediction of drug synergy based on target functional similarityMi Yang, Patricia Jaaks, Jonathan Dry, et al.
NPJ Systems Biology and Applications|October 12, 2019
Defining subpopulations of differential drug response to reveal novel target populationsNirmal Keshava, Tzen S Toh, Haobin Yuan, et al.
Drug Discovery Today|September 14, 2019
Applying synergy metrics to combination screening data: agreements, disagreements and pitfallsAnna H C Vlot, Natália Aniceto, Michael P Menden, et al.
Nature Methods|April 26, 2011
Adaptive informatics for multifactorial and high-content biological dataBjorn L Millard, Mario Niepel, Michael P Menden, et al.
International Journal of Molecular Sciences|September 28, 2021
Inferred Ancestral Origin of Cancer Cell Lines Associates with Differential Drug ResponsePhong B H Nguyen, Alexander J Ohnmacht, Samir Sharifli, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Biomolecules|July 2, 2020
Concise Polygenic Models for Cancer-Specific Identification of Drug-Sensitive Tumors from Their Multi-Omics ProfilesStefan Naulaerts, Michael P Menden, Pedro J Ballester
Expert Opinion on Drug Discovery|June 16, 2022
Can artificial intelligence accelerate preclinical drug discovery and precision medicine?Ali Farnoud, Alexander J Ohnmacht, Martin Meinel, et al.
Expert Opinion on Drug Discovery|October 27, 2023
Generative artificial intelligence empowers digital twins in drug discovery and clinical trialsMaria Bordukova, Nikita Makarov, Raul Rodriguez-Esteban, et al.
Plos One|May 11, 2026
Systematic identification of pan-cancer single-gene expression biomarkers in drug high-throughput screensGinte Kutkaite, Göksu Avar, Diyuan Lu, et al.
Expert Opinion on Drug Discovery|June 2, 2021
Artificial intelligence in early drug discovery enabling precision medicineFabio Boniolo, Emilio Dorigatti, Alexander J Ohnmacht, et al.
NPJ Systems Biology and Applications|June 4, 2020
Stratification and prediction of drug synergy based on target functional similarityMi Yang, Patricia Jaaks, Jonathan Dry, et al.
NPJ Systems Biology and Applications|October 12, 2019
Defining subpopulations of differential drug response to reveal novel target populationsNirmal Keshava, Tzen S Toh, Haobin Yuan, et al.
Drug Discovery Today|September 14, 2019
Applying synergy metrics to combination screening data: agreements, disagreements and pitfallsAnna H C Vlot, Natália Aniceto, Michael P Menden, et al.
Nature Methods|April 26, 2011
Adaptive informatics for multifactorial and high-content biological dataBjorn L Millard, Mario Niepel, Michael P Menden, et al.
International Journal of Molecular Sciences|September 28, 2021
Inferred Ancestral Origin of Cancer Cell Lines Associates with Differential Drug ResponsePhong B H Nguyen, Alexander J Ohnmacht, Samir Sharifli, et al.
Pageof 6